https://cd4receptor.com/index.....php/affect-from-the-
All calibration and dosage dimensions had been analyzed using the Radiochromic.com software application. The doses were calculated for 30 patients. The doses in contact with the applicator (prescription area) were 19.8±0.9Gy. Within the skin areas, the amounts were the following 1-2cm from the applicator, 1.86±0.77Gy; 2-5cm, 0.73±0.14Gy; andgreater than5cm, 0.28±0.17Gy. The dosage delivered to the pectoral muscle (tungsten shielding disc) was 0.51±0.27Gy. The study demonstrated the viability of XR-RV3 f
Like
Comment
Share
